Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 129

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 129
---
     
    10.31
     
    February 28, 2023

    10.29++
     
    Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated January 1, 2023.
     
    10-K
     
    001-39335
     
    10.32
     
    February 28, 2023

    10.30++
     
    Lease Amendment Agreement No.1 by and between the registrant Repare Therapeutics Inc. and NEOMED Institute dated April 1, 2023
     
    10-Q
     
    001-39335
     
    10.1
     
    May 9, 2023

    10.31†
     
    Fourth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 12, 2023
     
    10-Q
     
    001-39335
     
    10.1
     
    August 9, 2023

    10.32+
     
    Form of Amendment to Executive Employment Agreement
     
    10-Q
     
    001-39335
     
    10.2
     
    August 9, 2023

    10.33†
     
    Fifth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company dated March 14, 2024
     
    10-Q
     
    001-39335
     
    10.1 
     
    May 7, 2024

    10.34
     
    First Amendment to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REIT II Corp. PPP, dated August 26, 2024
     
    10-Q
     
    001-39335
     
    10.1
     
    November 7, 2024

    10.35
     
    Common Shares Sales Agreement, dated November 4, 2024, by and between Repare Therapeutics Inc. and TD Securities (USA)